AKT1 and glioblastoma: Moreover, cyclin D1 and Bcl-2 expression and Akt phosphorylation were found to be significantly decreased by ATX treatment, suggesting a protective role against colon cancer cells [434], MCF-7 breast cancer cells [435], and glioblastoma [426].